7Baggers

Infinera Quarterly Cash Flow Statements Chart

Quarterly
 | 
Annual
 
 Stock-Based Compensation  
 Operating Cash Flow  
 Investing Cash Flow  
 Financing Cash Flow  
 Free Cash Flow  
 Capital Expenditure  
20200328 20200627 20200926 20201226 20210327 20210626 20210925 20211225 20220326 20220625 20220924 20221231 20230401 20230701 20230930 20231230 20240330 20240629 20240928 20241228 -99.98-74.32-48.66-232.6728.3353.9979.65Milllion

Infinera Quarterly Cash Flow Statements Table

Quarterly
 | 
Annual
 
Unit: USD2024-12-28 2024-09-28 2024-06-29 2024-03-30 2023-12-30 2023-09-30 2023-07-01 2023-04-01 2022-12-31 2022-09-24 2022-06-25 2022-03-26 2021-12-25 2021-09-25 2021-06-26 2021-03-27 2020-12-26 2020-09-26 2020-06-27 2020-03-28 2019-12-28 2019-09-28 2019-06-29 2019-03-30 2018-12-29 2018-09-29 2018-06-30 2018-03-31 2017-12-30 2017-09-30 2017-07-01 2017-04-01 2016-12-31 2016-09-24 2016-06-25 2016-03-26 2015-12-26 2015-09-26 2015-06-27 2015-03-28 2014-12-27 2014-09-27 2014-06-28 2014-03-29 2013-12-28 2013-09-28 2013-06-29 2013-03-30 2012-06-30 2012-03-31 2011-12-31 2011-09-24 2011-06-25 2011-03-26 2010-12-25 2010-09-25 2010-06-26 2010-03-27 2009-12-26 2009-09-26 2009-06-27 2009-03-28 2008-12-27 2008-09-27 2008-06-28 2008-03-29 2007-12-29 2007-09-29 
                                                                      
  cash flows from operating activities:                                                                    
  net income-26,343,000 -14,313,000 -48,287,000 -61,395,000 12,873,000 -9,413,000 -20,263,000 -8,410,000 33,458,000 -11,930,000 -55,721,000 -41,850,000 -33,068,000 -53,794,000 -35,594,000 -48,322,000 -9,924,000 -35,896,000 -61,635,000 -99,268,000 -66,594,000 -84,767,000 -113,656,000 -121,601,000 -133,467,000 -32,610,000 -21,938,000 -26,280,000 -73,985,000 -37,231,000 -42,839,000 -40,451,000 -36,253,000 -11,297,000 11,312,000 11,808,000 12,168,000 8,510,000 17,906,000 12,366,000 8,410,000 4,843,000 4,780,000 -4,374,000 -10,178,000 3,347,000 -10,009,000 -15,279,000 -29,549,000 -20,612,000 -19,350,000 -21,806,000 -24,194,000 -16,394,000 -2,740,000 4,360,000 -9,561,000 -19,991,000 -18,651,000 -16,532,000 -27,111,000 -24,328,000 -6,688,000 14,937,000 42,885,000 27,594,000 -3,907,000 -5,526,000 
  adjustments to reconcile net income to net cash from operating activities:                                                                    
  depreciation and amortization15,589,000 15,758,000 15,541,000 15,445,000 19,381,000 20,002,000 19,799,000 19,602,000 19,819,000 21,305,000 21,134,000 21,572,000 23,350,000 20,925,000 18,762,000 20,546,000 25,877,000 22,894,000 25,924,000 25,445,000 28,643,000 29,038,000 31,204,000 30,939,000 50,155,000 17,089,000 16,274,000 16,976,000 16,606,000 16,768,000 16,672,000 15,951,000 15,725,000 15,873,000 15,225,000 14,666,000 13,683,000 9,244,000 6,264,000 6,586,000 6,577,000 6,527,000 6,499,000 6,314,000 5,988,000 5,953,000 6,287,000 6,334,000 5,696,000 5,528,000 4,504,000 4,921,000 4,219,000 4,215,000 4,025,000 3,875,000 3,736,000 3,983,000 4,483,000 4,166,000 4,020,000 3,878,000 4,098,000 3,408,000 2,853,000 2,616,000 2,674,000 2,727,000 
  non-cash restructuring charges and other related costs8,000 -20,000 23,000 29,000 17,000 28,000 1,019,000 136,000 -32,000 441,000 267,000 5,390,000 5,888,000                                                        
  amortization of debt discount and issuance costs        839,000 1,146,000 3,064,000 1,060,000 8,416,000 8,205,000 8,012,000 7,822,000 7,640,000 7,459,000 7,285,000 5,731,000 5,055,000 4,862,000 4,631,000 4,614,000 4,409,000 1,680,000 2,054,000 3,018,000 2,943,000 2,870,000 2,799,000 2,730,000 2,662,000 2,597,000 2,532,000 2,469,000 2,408,000 2,349,000 2,290,000 2,234,000 2,178,000 2,125,000 2,072,000 2,020,000 1,970,000 1,922,000                       
  operating lease expense2,347,000 2,399,000 2,291,000 2,215,000 1,062,000 2,123,000 2,131,000 2,148,000 2,218,000 2,216,000 2,285,000 2,702,000   3,298,000 5,228,000 4,433,000 4,250,000 4,669,000 5,204,000 -122,000                                                
  stock-based compensation expense12,200,000 14,389,000 9,801,000 14,531,000 12,757,000 15,744,000 17,998,000 15,651,000 16,597,000 13,696,000 17,783,000 12,939,000 13,267,000 13,632,000 13,939,000 10,974,000 12,919,000 12,063,000 12,776,000 11,703,000 11,729,000 9,805,000 13,047,000 8,713,000 9,016,000 11,367,000 12,044,000 10,983,000 10,296,000 12,167,000 12,380,000 10,877,000 11,342,000 10,211,000 10,993,000 7,987,000 8,712,000 8,451,000 8,209,000 7,208,000 7,547,000 7,371,000 6,804,000 6,672,000 8,174,000 7,643,000 8,184,000 7,975,000 10,930,000 9,437,000 12,730,000 12,580,000 12,482,000 12,365,000 10,374,000 14,444,000 12,607,000 12,910,000 11,642,000 10,085,000 8,912,000 6,736,000 5,976,000 6,555,000 6,355,000 4,933,000 3,683,000 3,163,000 
  gain on extinguishment of debt                                                                   
  other-215,000 313,000 291,000 -465,000 -140,000 -1,000 355,000 -1,037,000 326,000 24,000 79,000 789,000 681,000 376,000 1,025,000 2,065,000 547,000 890,000 1,848,000 1,153,000                                                 
  changes in assets and liabilities:                                                                    
  accounts receivable-52,146,000 -2,400,000 -20,676,000 115,440,000 -50,737,000 -4,968,000 7,977,000 86,239,000 -133,857,000 14,437,000 -31,420,000 81,816,000 -88,281,000 6,205,000 -2,378,000 38,671,000 -23,102,000 1,263,000 -16,249,000 70,238,000 -62,916,000 -27,695,000 5,462,000 49,754,000 6,617,000 -5,713,000 8,913,000 -30,928,000 10,771,000 -12,551,000 1,263,000 26,366,000 851,000 40,448,000 -9,569,000 2,165,000 -44,809,000 -16,302,000 21,749,000 23,391,000 -18,488,000 -15,420,000 -13,281,000 -6,762,000 -13,464,000 9,473,000 15,426,000 -5,094,000 9,244,000 15,172,000 -11,662,000 899,000 -12,820,000 18,897,000 -12,180,000 -9,366,000 3,763,000 11,028,000 -12,385,000 -1,551,000 -8,889,000 24,659,000 -23,318,000 8,471,000 -12,960,000 -3,989,000 -601,000 -11,536,000 
  inventory47,245,000 28,379,000 35,984,000 10,164,000 25,119,000 -29,821,000 -14,607,000 -38,555,000 -44,013,000 -23,289,000 -20,246,000 -1,979,000 -3,129,000 -18,773,000 -10,179,000 4,059,000 8,223,000 13,037,000 32,427,000 17,737,000 -19,501,000 7,301,000 -5,703,000 -24,937,000 -7,691,000 7,777,000 -6,374,000 -2,329,000 12,328,000 3,099,000 -12,374,000 -326,000 -3,017,000 -29,774,000 -15,149,000 -16,155,000 -8,215,000 3,873,000 -671,000 -12,103,000 -16,471,000 -908,000 -4,753,000 -3,354,000 567,000 -4,394,000 5,832,000 -5,041,000 -12,720,000 -12,050,000             -120,000 -1,180,000 1,502,000 -1,023,000 -700,000 1,554,000 
  prepaid expenses and other current assets-1,018,000 4,477,000 -37,797,000 -14,821,000 -7,128,000 5,434,000 10,373,000 1,004,000 2,925,000 -5,037,000 -8,453,000 -23,481,000                                          -3,357,000 1,275,000 -494,000 1,223,000 -708,000 87,000 -1,243,000 -597,000 -491,000 679,000 -1,360,000 -2,192,000 410,000 464,000 -1,273,000 
  accounts payable28,869,000 20,947,000 -13,431,000 -64,643,000 24,877,000 225,000 -54,000 -27,969,000 50,929,000 35,207,000 21,949,000 -19,829,000 34,380,000 9,000 21,499,000 -23,584,000 24,413,000 -40,466,000 -5,003,000 -72,355,000 66,785,000 11,761,000 28,165,000 -23,439,000 -26,774,000 1,796,000 5,172,000 19,286,000 -30,603,000 8,913,000 20,107,000 -3,180,000 -14,319,000 -6,596,000 1,702,000 -9,041,000 21,562,000 21,258,000 -13,280,000 -10,317,000 7,801,000 17,437,000 -4,348,000 -2,080,000 10,422,000 -6,644,000 -15,935,000 -8,045,000 -1,487,000 -7,266,000 12,230,000 4,884,000 978,000 -8,750,000 -13,863,000 9,987,000 2,413,000 2,624,000 -719,000 -1,794,000 5,195,000 -5,276,000 8,990,000 2,876,000 -891,000 5,792,000 -9,528,000 -1,931,000 
  accrued expenses and other current liabilities16,954,000 -752,000 -1,992,000 -2,642,000 6,100,000 4,536,000 -5,950,000 -44,749,000                                                             
  deferred revenue27,625,000 -25,539,000 -2,619,000 9,260,000 34,579,000 -34,544,000 -18,619,000 -6,676,000 51,587,000 -14,312,000 -13,156,000 -8,990,000 31,905,000 -9,841,000 -5,367,000 -8,944,000 43,455,000 -9,908,000 -3,599,000 -8,038,000 33,731,000 4,194,000 -19,200,000 6,933,000 16,663,000 -11,020,000 -2,942,000 5,293,000 7,841,000 -1,490,000 -2,878,000 12,943,000 22,244,000 -10,934,000 353,000 9,776,000 10,077,000 -3,516,000 1,419,000 2,797,000 13,060,000 -2,824,000 -539,000 -909,000 8,992,000 -6,095,000 100,000 4,340,000 -5,576,000 624,000 3,058,000 -2,766,000 -677,000 -16,000 3,491,000 -8,540,000 3,011,000 2,254,000 7,890,000 -4,558,000 2,449,000 -1,813,000 -10,049,000 -37,453,000 -65,585,000 -38,943,000 17,287,000 18,195,000 
  net cash from operating activities72,045,000 44,563,000 -59,954,000 24,026,000 79,652,000 -29,793,000 1,420,000 -1,769,000 -564,000 19,635,000 -72,419,000 15,788,000 1,369,000 -13,175,000 21,304,000 18,630,000 52,216,000 -36,427,000 -36,572,000 -91,517,000 -10,190,000 -37,193,000 -63,813,000 -56,154,000 -71,554,000 -20,411,000 6,991,000 -14,109,000 -1,009,000 -20,898,000 -3,048,000 3,030,000 -5,027,000 5,204,000 28,221,000 9,979,000 25,816,000 32,490,000 55,028,000 19,842,000 18,726,000 22,418,000 10,252,000 -15,433,000   17,924,000 -21,299,000 -22,744,000 -5,757,000 -5,081,000 4,105,000 -135,000 -854,000 7,010,000 10,020,000 11,230,000 2,277,000 -2,618,000 -8,300,000 -18,797,000 -2,931,000 -5,436,000 9,948,000 5,587,000 9,819,000 18,854,000 -2,004,000 
  capex-28,265,000 -24,090,000 -14,582,000 -8,076,000 -21,414,000 -13,318,000 -10,773,000 -16,809,000 -8,303,000 -11,024,000 -10,667,000 -16,059,000 -9,065,000 -6,525,000 -14,068,000 -11,721,000 -11,861,000 -8,146,000 -10,538,000 -8,464,000 -1,871,000 -12,547,000 -9,194,000 -6,590,000 -10,665,000 -5,524,000 -13,484,000 -8,019,000 -7,794,000 -11,047,000 -24,457,000 -14,743,000 -10,457,000 -9,600,000 -12,434,000 -10,844,000 -15,308,000 -10,612,000 -8,731,000 -7,367,000 -8,758,000 -4,379,000 -4,377,000 -5,608,000   -4,495,000 -4,936,000 -6,121,000 -13,649,000 -16,146,000 -5,914,000 -6,720,000 -10,602,000 -5,033,000 -5,942,000 -5,005,000 -4,692,000 -3,795,000 -2,840,000 -2,799,000 -5,960,000 -7,789,000 -7,869,000 -4,802,000 -2,481,000 -8,505,000 -2,987,000 
  free cash flows43,780,000 20,473,000 -74,536,000 15,950,000 58,238,000 -43,111,000 -9,353,000 -18,578,000 -8,867,000 8,611,000 -83,086,000 -271,000 -7,696,000 -19,700,000 7,236,000 6,909,000 40,355,000 -44,573,000 -47,110,000 -99,981,000 -12,061,000 -49,740,000 -73,007,000 -62,744,000 -82,219,000 -25,935,000 -6,493,000 -22,128,000 -8,803,000 -31,945,000 -27,505,000 -11,713,000 -15,484,000 -4,396,000 15,787,000 -865,000 10,508,000 21,878,000 46,297,000 12,475,000 9,968,000 18,039,000 5,875,000 -21,041,000   13,429,000 -26,235,000 -28,865,000 -19,406,000 -21,227,000 -1,809,000 -6,855,000 -11,456,000 1,977,000 4,078,000 6,225,000 -2,415,000 -6,413,000 -11,140,000 -21,596,000 -8,891,000 -13,225,000 2,079,000 785,000 7,338,000 10,349,000 -4,991,000 
  cash flows from investing activities:                                                                    
  purchase of property and equipment-28,265,000 -24,090,000 -14,582,000 -8,076,000 -21,414,000 -13,318,000 -10,773,000 -16,809,000 -8,303,000 -11,024,000 -10,667,000 -16,059,000 -9,065,000 -6,525,000 -14,068,000 -11,721,000 -11,861,000 -8,146,000 -10,538,000 -8,464,000 -1,871,000 -12,547,000 -9,194,000 -6,590,000 -10,665,000 -5,524,000 -13,484,000 -8,019,000 -7,794,000 -11,047,000 -24,457,000 -14,743,000 -10,457,000 -9,600,000 -12,434,000 -10,844,000 -15,308,000 -10,612,000 -8,731,000 -7,367,000 -8,758,000 -4,379,000 -4,377,000 -5,608,000 -7,463,000 -4,174,000 -4,495,000 -4,936,000 -6,121,000 -13,649,000 -16,146,000 -5,914,000 -6,720,000 -10,602,000 -5,033,000 -5,942,000 -5,005,000 -4,692,000 -3,795,000 -2,840,000 -2,799,000 -5,960,000 -7,789,000 -7,869,000 -4,802,000 -2,481,000 -8,505,000 -2,987,000 
  net cash from investing activities-28,265,000 -24,090,000 -14,582,000 -8,076,000 -21,414,000 -13,318,000 -10,773,000 -16,809,000 -8,303,000 -11,024,000 -10,667,000 -16,059,000 -9,065,000 -6,525,000 -14,068,000 -11,721,000 -11,861,000   -8,464,000 -2,649,000 -10,270,000 6,358,000 -6,048,000 -109,564,000 25,451,000 57,574,000 39,163,000 -4,947,000 15,473,000 -10,219,000 -50,860,000 38,176,000 -21,616,000 -44,167,000 15,492,000 -40,580,000 -75,628,000 18,489,000 6,244,000 -47,616,000 -5,585,000 -13,611,000 -29,247,000 -40,770,000 -65,262,000 -86,538,000 11,770,000 11,326,000 1,529,000 -12,835,000 3,917,000 -9,797,000 -6,453,000 1,839,000 -21,835,000 -14,160,000 -11,566,000 20,839,000 1,568,000 -41,018,000 -14,736,000 5,063,000 17,431,000 6,924,000 14,787,000 -122,045,000 -102,037,000 
  cash flows from financing activities:                                                                    
  proceeds from issuance of 2028 notes                                                                   
  repayment of 2024 notes                                                                
  payment of debt issuance cost    -78,000 -1,876,000 -154,000 -1,205,000 -10,463,000       -18,000 -364,000 -298,000 -1,775,000 -149,000                                                
  proceeds from asset-based revolving credit facility25,000,000                                                                 
  repayment of asset-based revolving credit facility-10,000,000 -15,000,000       -40,000,000                                                           
  repayment of mortgage payable-116,000 -114,000 -109,000 -131,000 -129,000 -128,000 -126,000 -127,000 -167,000 -121,000 -124,000 -121,000 -117,000 -103,000 -108,000 -22,000 -67,000 -67,000 -99,000                                                 
  principal payments on finance lease obligations-93,000 -97,000 -273,000 -99,000 -239,000 -313,000 -244,000 -227,000  -477,000 -177,000 -400,000                                                         
  payment of term license obligation-2,436,000 -2,734,000 -2,558,000 -2,590,000 -2,697,000 -2,215,000 -3,182,000 -2,323,000 -2,326,000 -1,770,000 -2,225,000 -1,418,000 -1,798,000 -1,544,000 -1,386,000 -2,544,000                                                     
  proceeds from issuance of common stock1,000 1,000   6,193,000 8,738,000 6,314,000 8,875,000 7,153,000 9,344,000 1,720,000 7,953,000 4,000 7,395,000 4,313,000 7,740,000 6,627,000 422,000 10,644,000 6,876,000 1,307,000 9,808,000 1,162,000 7,900,000 799,000 7,787,000 1,918,000 6,945,000 6,357,000 10,131,000 5,024,000 11,282,000 1,347,000 7,054,000 1,634,000 9,055,000 6,936,000 5,560,000 88,000 7,005,000 59,000 4,252,000 803,000 4,909,000 7,007,000 5,623,000 2,321,000 4,397,000 765,000 3,783,000 427,000 4,335,000 240,000 4,078,000 1,120,000 6,044,000 1,438,000 47,000 
  tax withholding paid on behalf of employees for net share settlement-269,000 -261,000 -1,397,000 -202,000 -248,000 -549,000 -568,000 -1,100,000 -368,000 -962,000 -1,860,000 -524,000 -2,454,000                                                        
  net cash from financing activities-12,913,000 -11,952,000 -4,333,000 -3,022,000 -3,313,000 2,910,000 9,309,000 4,807,000 -4,326,000 45,429,000 34,831,000 6,412,000 -4,815,000 3,814,000 -28,074,000 -72,469,000 57,313,000 36,390,000 -14,562,000 255,021,000 23,237,000 32,799,000 -450,000 16,324,000 -1,262,000 349,049,000 -150,445,000 10,547,000 -71,000 6,736,000 5,755,000 9,662,000 932,000 9,640,000 -24,781,000 5,343,000 2,593,000 6,463,000 5,746,000 6,181,000 5,024,000 11,055,000 1,347,000 5,435,000 1,631,000 9,013,000 151,399,000 4,067,000 81,000 6,173,000 50,000 4,125,000 -484,000 4,822,000 6,920,000 5,524,000 2,233,000 4,308,000 666,000 3,531,000 420,000 4,327,000 -2,099,000 6,107,000 1,581,000 6,112,000 105,590,000 -4,575,000 
  effect of exchange rate changes on cash, cash equivalents, and restricted cash                                                                    
  net change in cash, cash equivalents, and restricted cash        -20,814,000                                                            
  cash, cash equivalents, and restricted cash at beginning of period                                                                   
  cash, cash equivalents, and restricted cash at end of period        -20,814,000                                                            
  amortization of debt issuance costs and discount 925,000 917,000 908,000  862,000                                                               
  proceeds from issuance of 2028 notes, net of discount                                                                   
  effect of exchange rate changes on cash -8,596,000 2,358,000 5,376,000  78,000 -2,931,000 -5,698,000 -7,621,000 795,000 -591,000 -4,634,000                 330,000 911,000 1,674,000 1,185,000 -2,436,000 -612,000 -867,000 59,000 169,000 -240,000 132,000 -139,000 -503,000 -331,000 70,000 164,000 55,000 -103,000 -572,000 -206,000 -384,000 306,000 -317,000 -432,000 -10,000 188,000 -96,000 199,000 -52,000 -61,000 27,000 -5,000 175,000 -59,000       
  net change in cash, cash equivalents and restricted cash -75,000 -76,511,000 18,304,000  -40,123,000 -2,975,000 -19,469,000          -8,413,000 -59,271,000 150,671,000  -17,891,000 -56,725,000 -47,091,000  353,253,000 -88,040,000 35,543,000                                         
  cash, cash equivalents and restricted cash at beginning of period 173,859,000  189,203,000         132,797,000 242,337,000 121,486,000                                         
  cash, cash equivalents and restricted cash at end of period -75,000 -76,511,000 192,163,000  -40,123,000 -2,975,000 169,734,000         99,599,000 -8,413,000 -59,271,000 283,468,000 12,167,000 -17,891,000 -56,725,000 195,246,000 -179,905,000 353,253,000 -88,040,000 157,029,000                                         
  repayment of third-party manufacturing funding                                                                    
  supplemental disclosures of cash flow information:                                                                    
  cash paid for income taxes     972,000 7,020,000 1,963,000 5,796,000 4,895,000 2,468,000 1,967,000 2,802,000   4,355,000                             599,000 388,000 938,000 210,000 266,000 329,000 635,000 287,000 123,000 442,000 -143,000 435,000 112,000 335,000 197,000 132,000 171,000 942,000 178,000 265,000 530,000 63,000 59,000 -19,000 
  cash paid for interest     10,503,000 145,000 10,931,000   858,000 7,137,000 1,090,000 7,309,000 2,208,000 7,654,000 1,223,000 7,095,000    8,682,000 372,000 4,315,000 2,222,000 4,000 1,319,000 9,000 1,322,000 1,000 1,313,000 3,000 1,331,000 35,000 1,373,000 37,000 1,330,000 4,000   1,312,000                     3,000 24,000 270,000 
  supplemental schedule of non-cash investing and financing activities:                                                                    
  unpaid debt issuance cost                 -351,000                                                   
  property and equipment included in accounts payable and accrued liabilities      5,839,000 10,229,000    1,477,000    255,000                                                     
  amortization of debt issuance costs       847,000                                                             
  transfer of inventory to fixed assets       1,099,000   1,668,000 2,037,000 -1,854,000 2,398,000 694,000 1,041,000 630,000 335,000     390,000 1,805,000 2,622,000 -519,000 791,000 893,000 1,840,000 1,023,000 1,949,000 138,000 386,000 1,202,000 2,600,000 1,409,000 3,453,000 3,656,000 802,000 1,403,000 731,000 860,000 375,000 603,000 -1,214,000 1,988,000                       
  unpaid term licenses       7,134,000   -1,947,000 9,290,000 -519,000 51,000 -726,000 10,533,000                                                     
  proceeds from issuance of common stock from at-the-market equity offering, net of issuance costs of 3,380                                                                    
  proceeds from issuance of 2027 notes                194,500,000                                                 
  principal payments on financing lease obligations            -446,000 -366,000 -510,000 -309,000 -537,000 -128,000                                                   
  accrued liabilities and other current liabilities         1,252,000 -9,984,000 -14,351,000                                                         
  net change in cash          -48,846,000 1,507,000                                                         
  cash and restricted cash at beginning of period          202,521,000 315,383,000                                                     
  cash and restricted cash at end of period          -48,846,000 204,028,000 -13,879,000 -16,830,000 -16,315,000 249,545,000                                                     
  repayment of revolving line of credit               -77,000,000                                                   
  cash           191,937,000                                                         
  short-term restricted cash           6,528,000                                                         
  long-term restricted cash           5,563,000                                                         
  total cash and restricted cash           204,028,000                                                         
  proceeds from sales of available-for-sale investments                        29,925,000   6,533,000                                      
  proceeds from maturities of investments                    -1,499,000 1,499,000 14,543,000 10,542,000  47,944,000 50,168,000   32,324,000 46,679,000   27,955,000 63,759,000    91,280,000                             
  acquisition of business, net of cash acquired                    -10,000,000                                            
  proceeds from sale of non-marketable equity investments                                                                  
  proceeds from mortgage payable                                                                    
  proceeds from short-term borrowings                                                                    
  proceeds from revolving line of credit                55,000,000                                                 
  third-party manufacturer funding for transfer expenses incurred                                                                    
  non-cash operating lease expense                                                                    
  prepaid expenses and other assets             -6,359,000 663,000 20,669,000 -10,648,000 1,482,000 -8,217,000 -18,744,000 -40,151,000 -22,512,000 -25,722,000 -5,236,000 -13,752,000 2,103,000 2,141,000 -3,950,000 7,172,000 -7,239,000 -2,360,000 -5,767,000 -3,876,000 -1,297,000 -54,000 -274,000 2,810,000 -4,978,000 -2,221,000 1,141,000 -3,359,000 -1,576,000 408,000 -3,797,000 3,406,000 -4,315,000 -3,651,000 -432,000 -640,000 2,173,000 7,224,000 6,007,000                 
  accrued liabilities and other incomes             22,881,000 8,210,000 -11,964,000 -34,195,000 -13,570,000 -27,856,000 -32,083,000 41,851,000 18,279,000 14,783,000 -20,255,000 9,264,000 -16,137,000 -8,436,000 -6,181,000 -4,085,000 -5,918,000 7,635,000 -12,027,000 -3,432,000 -2,052,000 9,508,000 -15,036,000 4,827,000 -8,687,000 14,386,000 -12,895,000 11,209,000 3,975,000 10,130,000 -13,448,000 9,632,000 1,860,000 6,081,000 -6,301,000 -1,262,000 -1,010,000 664,000 -6,446,000 11,028,000 -15,528,000 16,052,000 -3,695,000 3,341,000 -6,502,000 10,215,000 5,766,000 5,882,000 -2,899,000 12,110,000 -1,821,000 2,627,000 -9,529,000 8,251,000 2,909,000 
  proceeds from issuance of common stock from at-the-market equity offering, net of issuance costs of 954                                                                    
  proceeds from credit facility                                                                    
  repayment of credit facility                                                                   
  repayment of third party manufacturing funding                -1,386,000                                                   
  effect of exchange rate changes on cash and restricted cash             -944,000 4,523,000 -278,000  -230,000 2,401,000 -4,369,000  -3,227,000 1,180,000 -1,213,000  -836,000 -2,160,000 -58,000                                         
  net change in cash and restricted cash             -16,830,000 -16,315,000 -65,838,000                                                     
  non-cash restructuring charges and related costs              -586,000 1,410,000  75,000 1,058,000 1,760,000                                                 
  minimum tax withholding paid on behalf of employees for net share settlement              -1,460,000 -1,938,000 -54,000 -640,000   -33,000 -39,000   -51,000 -129,000 -867,000 -97,000 -71,000 -140,000 -672,000 -151,000 -65,000 -510,000 -638,000 -2,444,000 -184,000 -482,000 -611,000 -3,950,000 -227,000 -1,619,000                         
  cash paid (received) for income taxes                                                                    
  non-cash restructuring and other related                                                                    
  interest accretion related to financing lease obligation                                                                    
  impairment of non-marketable equity investment                                                                    
  purchase of available-for-sale investments                        -2,986,000 -37,966,000 -14,395,000 -23,432,000 -84,422,000 -6,060,000 -20,966,000 -59,658,000 -37,393,000 -59,797,000 -14,000,000 -32,918,000 -80,022,000 -88,126,000 -55,776,000 -78,273,000 -80,223,000 -81,612,000 -75,700,000 -110,805,000 -20,023,000 -20,946,000 -21,907,000 -66,505,000 -53,795,000 -45,985,000 -107,049,000 -40,823,000 -92,072,000 -44,579,000 -75,656,000 -27,532,000 -52,401,000    -49,251,000     
  proceeds from issuance of 2024 notes                                                                    
  purchase of capped call transactions                                                                   
  repayment of 2018 notes                                                                    
  net change in cash and cash equivalents                            -5,697,000 2,222,000 -5,838,000 -36,983,000 31,645,000 -7,384,000 -41,594,000 30,873,000 -12,002,000 -36,915,000 79,395,000 32,128,000 -24,369,000 27,557,000 -1,942,000 -39,081,000 -13,299,000 -43,582,000 82,213,000 -5,668,000 -11,721,000 2,251,000 -18,183,000 11,715,000 -10,426,000 -2,297,000 15,673,000 -6,092,000 -749,000 -5,042,000 18,914,000 -3,206,000 -59,220,000 -13,399,000 -2,669,000 33,476,000   2,386,000 -108,595,000 
  common stock issued in connection with acquisition                                                                   
  proceeds from sale of assets                                                                    
  cash paid (refund) for income taxes                                                                    
  net cash (used in)/provided by investing activities                                                                    
  cash paid for income taxes, net of refunds                     2,318,000 12,253,000 1,353,000 3,372,000 1,110,000 673,000 1,537,000 1,531,000 1,476,000 1,130,000 1,553,000 1,068,000 2,320,000 1,683,000 1,554,000 2,018,000 1,071,000 584,000 897,000 641,000 574,000 179,000 303,000                         
  acquisition of non-controlling interest                                                                    
  non-cash restructuring charges and related                     4,064,000                                               
  other loss                     569,000 -1,765,000 1,775,000 1,090,000 47,000    -75,000                                       
  proceeds from issuance of debt                     28,750,000 8,584,000                                          
  repayment of debt                     -101,000                                             
  operating lease amortization, net of accretion                                                                    
  non-cash restructuring and related credits                       19,882,000                                            
  operating lease expense, net of accretion                       16,704,000                                             
  supplemental schedule of non-cash investing activities:                                                                    
  non-cash restructuring and other related credits                           -81,000                                         
  impairment of intangible assets                            252,000                                     
  realized gain on sale of non-marketable equity investments                                                                   
  proceeds from maturities and calls of investments                            40,906,000    32,344,000    34,517,000 35,234,000   39,914,000 51,847,000 59,227,000 57,063,000 48,481,000 14,496,000 28,812,000 33,835,000 38,430,000 32,034,000   41,095,000 109,416,000   39,885,000 68,598,000           
  purchase of non-marketable equity investments                                                                    
  acquisition of noncontrolling interest                            -471,000                                    
  impairment on non-marketable equity investment                                                                    
  proceeds from sale of non-marketable equity investment                                                                    
  other gain                           84,000    -60,000  177,000     21,000 -19,000 -24,000 37,000 -2,000 -20,000 -243,000 -479,000 -22,000 2,000 -44,000 -274,000 -19,000  -21,000 -25,000 -25,000      22,000 18,000 -33,000  
  non-cash restructuring and other related costs                                                                    
  amortization of premium on investments                            104,000 125,000 114,000 120,000 144,000 192,000 252,000 481,000 512,000 613,000 838,000 954,000 1,052,000 973,000 919,000 828,000 669,000 420,000 136,000 314,000 480,000 618,000 925,000 1,072,000 1,231,000 987,000  1,232,000 981,000 540,000           
  realized gain on sale of cost-method investments                                                                    
  impairment of cost-method investment                                                                    
  other (gain) loss                                    467,000                      -21,000          
  purchase of cost-method investments                                                                    
  proceeds from sale of cost-method investments                                                                    
  realized gain from forward contract for business acquisition                                                                   
  change in restricted cash                            -93,000 1,415,000 1,348,000 1,626,000 866,000 -4,890,000 -30,000 -30,000 8,000 -163,000 -62,000 352,000 -1,251,000 171,000 -12,000 -479,000 -179,000 116,000 -50,000 44,000 -37,000 -193,000 -279,000 -311,000 1,505,000 68,000 -16,000 -108,000 -52,000 99,000           
  security pledge related to acquire noncontrolling interest                                                                    
  excess tax benefit from stock option transactions                                                              2,340,000 -2,029,000 -488,000 -71,000   
  cash and cash equivalents at beginning of period                            162,641,000 149,101,000 86,495,000 124,330,000 104,666,000 94,458,000 113,649,000 109,859,000 166,770,000 91,209,000 
  cash and cash equivalents at end of period                            -5,697,000 2,222,000 -5,838,000 125,658,000 31,645,000 -7,384,000 -41,594,000 179,974,000 -12,002,000 -36,915,000 79,395,000 118,623,000 -24,369,000 27,557,000 -1,942,000 85,249,000 -13,299,000 -43,582,000 82,213,000 98,998,000 -11,721,000 96,709,000 -18,183,000 11,715,000 -10,426,000 111,352,000 15,673,000 -6,092,000 -749,000 104,817,000 18,914,000 -3,206,000 -59,220,000 153,371,000 -2,669,000 33,476,000 14,033,000 121,930,000 2,386,000 -108,595,000 
  accrued warranty                             -336,000 -3,713,000 -4,398,000  -2,344,000 1,032,000 1,133,000 2,075,000 7,343,000 2,900,000 -1,501,000 -766,000 -142,000 1,563,000 3,477,000 -254,000 3,461,000 3,029,000 190,000 716,000 121,000 1,760,000 411,000 535,000 -1,262,000 497,000 -397,000 671,000 -489,000 1,002,000 -233,000 668,000 -238,000 -737,000 116,000 -467,000 1,035,000 622,000 -665,000 
  purchase of cost-method investment                                                 -4,500,000               
  security pledge to acquire noncontrolling interest                             5,120,000 476,000                                     
  impairment on acquired in-process research and development                                                                    
  security pledge related to squeeze-out proceedings                                -165,000                                    
  benefit from (recovery of) doubtful accounts                                                                    
  realized gain from forward contract                                                                    
  warrant exercise                                                                    
  proceeds from sale of available-for-sale investments                                     57,305,000 7,997,000 2,001,000  8,052,000    2,850,000 5,194,000  3,035,000               
  unrealized gain from forward contract                                                                    
  supplemental schedule of non-cash financing activities:                                                                    
  reimbursement of manufacturing capacity advance                                              50,000 75,000 150,000 150,000 75,000               
  supplemental schedule of non-cash financing activities                                                                    
  non-cash settlement for manufacturing capacity advance                                              275,000                   
  (recovery of) benefit from other receivables                                            -88,000                     
  non-cash restructuring and other costs                                                  -129,000     569,000          
  benefit from doubtful accounts                                            2,000 13,000                       
  non-cash tax benefit                                               59,000 -59,000 35,000 -9,000 -43,000 -78,000 95,000 -47,000 -94,000 -270,000           
  other receivables                                            -696,000 502,000 2,187,000 -558,000 -899,000 422,000 -182,000                1,508,000  
  deferred inventory costs                                            555,000 -376,000 -413,000 629,000 2,743,000 1,167,000 1,450,000 1,153,000 -326,000 -278,000 814,000 2,163,000 -494,000 -1,555,000 -6,201,000 1,193,000 -1,840,000 668,000 4,912,000 17,483,000 31,338,000 22,805,000 -1,932,000 -5,271,000 
  proceeds from disposal of assets                                                158,000 104,000 40,000 108,000 91,000 85,000 493,000 103,000 54,000 49,000 112,000 309,000 439,000 332,000   
  advance to secure manufacturing capacity                                                -1,500,000               
  repurchase of common stock                                            -3,000 -42,000 -6,000 -1,493,000 -7,000 -832,000 -9,000 -39,000   -12,000 -2,000 -12,000 -4,000 -7,000 -8,000 1,000 -27,000 -3,000 -9,000 
  payments for purchase of assets under financing arrangement                                                -88,000 -87,000 -87,000 -87,000 -87,000 -88,000 -87,000           
  net provided by (cash used) in operating activities                                                                    
  benefit from other receivables                                                                   
  unrealized loss on put rights                                                      -408,000 2,104,000           
  unrealized holding gain for trading securities                                                      408,000 -2,104,000           
  proceeds from maturities and calls of investments, and exercise of put rights                                                  68,983,000    47,671,000              
  inventories                                                   -936,000 9,283,000 3,986,000 6,644,000 -4,753,000 -11,825,000 -3,209,000 4,110,000 -165,000 -7,683,000 -4,880,000       
  net credit impairment losses in earnings                                                                   
  recovery of doubtful accounts                                                                    
  tax benefit of stock option transactions                                                                    
  reduction of tax benefit from stock option transactions                                                                    
  purchase of assets under financing arrangement                                                                    
  gain on disposal of assets                                                     -104,000 -40,000 -108,000 -91,000 60,000 -167,000 -71,000 -31,000 -15,000  -236,000     
  other non-current assets                                                     4,482,000 -8,847,000 1,810,000 1,474,000 1,627,000 -2,550,000 -5,036,000 182,000 59,000 -4,117,000 -1,650,000 906,000 -1,220,000 1,972,000 -1,865,000 
  amortization of premium (accretion of discount) on investments                                                                    
  unrealized (gain) loss on put rights                                                                    
  unrealized holding (gain) loss for trading securities                                                                    
  tax benefit (reversal) of stock option transactions                                                                    
  reduction of (excess) tax benefit from stock option transactions                                                                    
  excess (reduction of) tax benefit from stock option transactions                                                                    
  tax benefit (reversal) from stock option transactions                                                                    
  net credit impairment losses recognized in earnings                                                                    
  asset impairment charges                                                                  
  amortization of debt discount                                                                  
  revaluation of warrant liablities                                                                    
  principal payments on loan obligations                                                                   
  proceeds from loans                                                                  
  proceeds from initial public offering, net of issuance costs                                                                  -167,000 
  proceeds from follow-on offering, net of issuance costs                                                                    
  proceeds from exercise of warrants                                                                    
  proceeds from repayment of non-recourse notes                                                                    
  excess (reduction of) tax benefit from stockoption transactions                                                                    
  payments for purchase of assets underfinancing arrangement                                                                    
  (accretion of discount) amortization of premium on investments                                                                    
  unrealized holding gains for trading securities                                                           -1,619,000 -550,000 -972,000       
  (excess) reduction of tax benefit from stock option transactions                                                                    
  proceeds from maturities and calls of investments and restricted cash                                                                    
  accretion of investment discount                                                            81,000 14,000 -12,000 -156,000 -264,000 -461,000   
  put rights                                                            -418,000 1,967,000       
  tax benefit from stock option transactions                                                              -1,995,000 1,965,000 388,000 235,000   
  proceeds from maturities and call of investments and restricted cash                                                                    
  purchases of available-for-sale investments                                                             -31,629,000    -78,300,000   
  proceeds from maturities of investments and restricted cash                                                             22,804,000  40,595,000 45,704,000 36,600,000   
  issuance of warrants                                                                    
  in-process research and development                                                                    
  unrealized gain, put rights                                                                    
  unrealized loss, trading securities                                                                    
  revaluation of warrant liabilities                                                                    
  gain on disposal of fixed assets                                                                  -6,000 -26,000 
  purchases of available-for-sale investments and restricted cash                                                                    
  proceeds from maturities of available-for-sale investments                                                                    
  acquisition of certain assets                                                                    
  cash payments for debt issuance costs                                                                    
  proceeds from issuance of preferred stock, net of issuance costs                                                                    
  supplemental schedules of non-cash investing and financing activities                                                                    
  debt assumed in connection with acquisition of certain assets of little optics, inc.                                                                    
  issuance of series g convertible preferred stock warrants                                                                    
  proceeds from sale of investments                                                               33,647,000     
  principal payments on loan obligation                                                                    
  effect of exchange rate changes                                                               -10,000   -13,000 21,000 
  gain on sale of assets                                                                 -332,000   
  proceeds from sales of investments                                                                 58,636,000   
  effect of exchange rate changes on cash and cash equivalents                                                                 3,000   
  net increase in cash and cash equivalents                                                                 30,721,000   
  gain on sale of assets held for sale                                                                  -361,000 -362,000 
  proceeds from disposition of acquired assets                                                                    
  proceeds from disposal of fixed assets                                                                  86,000 30,000 
  proceeds from sales of assets held for sale                                                                  419,000  
  issuance of warrants in connection with debt arrangements                                                                    
  debt assumed in connection with acquisition of certain assets of big bear networks, inc.                                                                    
  proceeds from maturities and sales of investments                                                                    
  proceeds from excercise of warrants                                                                    
  proceeds from non-recourse notes                                                                    
  unrealized loss on investments                                                                    
  purchase of short-term investments                                                                    
  proceeds from sale or maturity of short-term investments                                                                    
  proceeds from sale of assets held for sale                                                                    
  proceeds from issuance of convertible preferred stock, net of issuance costs                                                                    

We provide you with 20 years of cash flow statements for Infinera stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Infinera stock. Explore the full financial landscape of Infinera stock with our expertly curated income statements.

The information provided in this report about Infinera stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.